The potential for personalized cancer treatment is fueling the need to identify T cell responses against neoantigens and other cancer-specific epitopes for the success of immunotherapy. Continuous ...

MHC-peptide exchange is considered to be tricky by researchers. However, with the right set of tools and protocols, this peptide-MHC exchange can be done easily, quickly, and provides robust ...

ProImmune, a leader in services for understanding and managing adaptive immune responses, announced the introduction of ProT2, a range of human MHC class II tetramer reagents for tetramer analyses in ...